GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 44 filers reported holding GENOCEA BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $795,000 | +248.7% | 635,802 | +223.7% | 0.00% | – |
| Q4 2021 | $228,000 | -68.6% | 196,433 | -47.9% | 0.00% | – |
| Q3 2021 | $725,000 | +8.4% | 377,345 | +31.9% | 0.00% | – |
| Q2 2021 | $669,000 | -5.8% | 286,041 | +9.2% | 0.00% | -100.0% |
| Q1 2021 | $710,000 | +81.1% | 261,856 | +61.7% | 0.00% | – |
| Q4 2020 | $392,000 | +71.9% | 161,961 | +62.8% | 0.00% | – |
| Q3 2020 | $228,000 | +21.9% | 99,489 | +22.2% | 0.00% | – |
| Q2 2020 | $187,000 | +750.0% | 81,385 | +539.8% | 0.00% | – |
| Q1 2020 | $22,000 | -75.8% | 12,721 | -71.0% | 0.00% | – |
| Q4 2019 | $91,000 | -73.1% | 43,883 | -62.4% | 0.00% | -100.0% |
| Q3 2019 | $338,000 | -55.6% | 116,846 | -39.8% | 0.00% | 0.0% |
| Q2 2019 | $761,000 | – | 194,242 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $435,000 | 25.16% |
| COMMODORE CAPITAL LP | 3,079,756 | $3,573,000 | 0.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $2,288,000 | 0.26% |
| NEA Management Company, LLC | 10,376,936 | $12,037,000 | 0.24% |
| BVF INC/IL | 4,012,404 | $4,654,000 | 0.17% |
| Avoro Capital Advisors LLC | 5,084,184 | $5,898,000 | 0.10% |
| Boxer Capital, LLC | 1,134,453 | $1,316,000 | 0.05% |
| Ikarian Capital, LLC | 196,821 | $228,000 | 0.03% |
| Empirical Asset Management, LLC | 10,000 | $12,000 | 0.01% |
| Point72 Asset Management, L.P. | 2,652,974 | $3,077,000 | 0.01% |